Cell MedX Corp. announced that in August 2020, Health Canada granted Cell MedX (Canada) Corp., the Company's wholly-owned subsidiary, a Class II Medical Device License for its innovative eBalance Pro System. The eBalance Pro System is a non-invasive, fully automated microcurrent electrotherapy system that administers pre-programmed algorithms through the epidermis with the touch of a button. The eBalance Pro System includes the eBalance Console which acts as the central controller for three (3) pre- programmed microcurrent algorithms (Wellness, Pain Management, & Dual) referred to as Treatment Options. Treatments are administered to patients using Hand Bars, Foot Plates, and/or Pen Probes along with the proprietary ePro Gel specially formulated to aid in the conduction of microcurrent. Thegeneral duration of each treatment is controlled by the eBalance Console. The Hand Bars and Foot Plates are used for general wellness and pain management while the Pen Probes are used in localized pain management. The eBalance Pro System is a safe, effective, easy-to-use therapeutic option forpractitioners who want to deliver frequency-specific microcurrent to clients in their practice.